SANOFI INTERESTED IN ACQUIRING STERLING U.S. Rx BUSINESS
Executive Summary
SANOFI INTERESTED IN ACQUIRING STERLING U.S. Rx BUSINESS in the wake of Kodak's decision to divest its worldwide prescription and OTC pharmaceutical business. Sterling's worldwide joint venture partner Sanofi said it is interested in buying out all portions of the business covered by the joint venture, which includes Sterling's worldwide prescription drug businesses and Sterling's international OTC operations.